169 related articles for article (PubMed ID: 27092883)
1. Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer.
Shang Z; Li Y; Hsu I; Zhang M; Tian J; Wen S; Han R; Messing EM; Chang C; Niu Y; Yeh S
Oncotarget; 2016 May; 7(19):27325-35. PubMed ID: 27092883
[TBL] [Abstract][Full Text] [Related]
2. Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.
Shang Z; Li Y; Zhang M; Tian J; Han R; Shyr CR; Messing E; Yeh S; Niu Y; Chang C
Mol Cancer Ther; 2015 Nov; 14(11):2586-94. PubMed ID: 26264279
[TBL] [Abstract][Full Text] [Related]
3. A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.
Chen F; Zhang G; Cao Y; Wakim B; See WA
J Urol; 2013 Mar; 189(3):1104-9. PubMed ID: 22999999
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo.
Jinesh GG; Lee EK; Tran J; Kamat AM
Urol Oncol; 2013 Nov; 31(8):1676-1682. PubMed ID: 22717623
[TBL] [Abstract][Full Text] [Related]
5. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
[TBL] [Abstract][Full Text] [Related]
6. Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.
Thiel T; Ryk C; Chatzakos V; Hallén Grufman K; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
Cancer Lett; 2014 Jun; 348(1-2):119-25. PubMed ID: 24657658
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of Bacillus Calmette‑Guérin by targeting macrophages against bladder cancer in a NOD/scid IL2Rg‑/‑ mouse model.
Tan QL; Zhou CY; Cheng L; Luo M; Liu CP; Xu WX; Zhang X; Zeng X
Mol Med Rep; 2020 Jul; 22(1):362-370. PubMed ID: 32319653
[TBL] [Abstract][Full Text] [Related]
8. 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.
Hsu JW; Yin PN; Wood R; Messing J; Messing E; Lee YF
Oncotarget; 2013 Dec; 4(12):2397-406. PubMed ID: 24353168
[TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
[TBL] [Abstract][Full Text] [Related]
10. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer.
Bunimovich-Mendrazitsky S; Claude Gluckman J; Chaskalovic J
J Theor Biol; 2011 May; 277(1):27-40. PubMed ID: 21334346
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
[TBL] [Abstract][Full Text] [Related]
13. FGFBP1 as a potential biomarker predicting bacillus Calmette-Guérin response in bladder cancer.
Li F; Zhang H; Wang Y; Yao Z; Xie K; Mo Q; Fan Q; Hou L; Deng F; Tan W
Front Immunol; 2022; 13():954836. PubMed ID: 36119059
[TBL] [Abstract][Full Text] [Related]
14. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
[TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.
Prack Mc Cormick B; Belgorosky D; Langle Y; Balarino N; Sandes E; Eiján AM
Nitric Oxide; 2017 Apr; 64():22-30. PubMed ID: 28126499
[TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin.
Chen F; Zhang G; Iwamoto Y; See WA
J Urol; 2003 Aug; 170(2 Pt 1):605-10. PubMed ID: 12853840
[TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Chen F; Zhang G; Cao Y; Payne R; See WA
J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
[TBL] [Abstract][Full Text] [Related]
18. Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non-muscle-invasive bladder cancer.
Bachir BG; Dragomir A; Aprikian AG; Tanguay S; Fairey A; Kulkarni GS; Breau RH; Black PC; Kassouf W
Cancer; 2014 Aug; 120(16):2424-31. PubMed ID: 24752448
[TBL] [Abstract][Full Text] [Related]
19. Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.
Ferrari KL; de Camargo JA; Rocha GZ; Carvalheira JB; Saad MJ; Billis A; Reis LO
J Urol; 2015 Feb; 193(2):682-9. PubMed ID: 25200808
[TBL] [Abstract][Full Text] [Related]
20. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
